Selling Congress On DTC User Fees: AstraZeneca Uses Guilt
Executive Summary
AstraZeneca U.S. CEO Tony Zook wants Congress to understand the company's "disappointment" in the failure of FDA's user fee program for direct-to-consumer advertising to get off the ground. The system is "good for patients, good public policy, and a sensible way to help alleviate concerns that have been expressed about the tone and content of some DTC," Zook says in an April 24 letter to the leadership of the Senate Health and House Commerce Committees.